These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 30139906)
1. Association between Xu MY; Cao B; Chen Y; Musial N; Wang S; Yin J; Liu L; Lu QB BMJ Open; 2018 Aug; 8(8):e022374. PubMed ID: 30139906 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms]. Chen L; Zhang Y; Chen M; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990 [TBL] [Abstract][Full Text] [Related]
3. [Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for Wang SS; Guo ZP; Zhao XY Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):186-191. PubMed ID: 36647665 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer. Gong X; Zhang H J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318 [TBL] [Abstract][Full Text] [Related]
5. Reference intervals for gastrointestinal tumor markers (AFP, CEA, CA199 and CA724) in healthy adults of Han nationality in Chongqing by Roche ECLIA system. Yu H Scand J Clin Lab Invest; 2019 Nov; 79(7):484-490. PubMed ID: 31599689 [TBL] [Abstract][Full Text] [Related]
6. Serum CA724 has no diagnostic value for gastrointestinal tumors. Cao H; Zhu L; Li L; Wang W; Niu X Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593 [TBL] [Abstract][Full Text] [Related]
7. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population. Chen XZ; Zhang WH; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK Tumour Biol; 2014 Sep; 35(9):9015-22. PubMed ID: 24906604 [TBL] [Abstract][Full Text] [Related]
8. Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study. Chen XZ; Zhang WH; Chen HN; Liu JP; He D; Liu Y; Liu K; Chen XL; Mo XM; Zhou ZG; Hu JK Oncotarget; 2016 Apr; 7(17):23647-57. PubMed ID: 27027339 [TBL] [Abstract][Full Text] [Related]
9. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. Yang J; Tang A; Ma J; Sun X; Ming L Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773 [TBL] [Abstract][Full Text] [Related]
10. [A preliminary study of retinoblastoma-related serum tumor markers]. Liu ZP; Zhou KY; Chen LL; Xiao ZH; Chen YZ Zhongguo Dang Dai Er Ke Za Zhi; 2017 Mar; 19(3):318-321. PubMed ID: 28302204 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of serum tumor markers in various pathologic subtypes of gastric cancer. Pang C; Ma Y; Shi W; Zi M; Chen J; Liang C; Li X; Liu Z; Du Y J Gastrointest Surg; 2024 May; 28(5):694-702. PubMed ID: 38458911 [TBL] [Abstract][Full Text] [Related]
12. The association of five preoperative serum tumor markers and pathological features in patients with breast cancer. Lian M; Zhang C; Zhang D; Chen P; Yang H; Yang Y; Chen S; Hong G J Clin Lab Anal; 2019 Jun; 33(5):e22875. PubMed ID: 30843272 [TBL] [Abstract][Full Text] [Related]
13. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory. Hui L; Rixv L; Xiuying Z Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289 [TBL] [Abstract][Full Text] [Related]
14. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872 [TBL] [Abstract][Full Text] [Related]
16. [Application of multiple tumor markers's protein chip in the screen program of the elderly]. Yan HY; Zhong RH; Li J; Luo XH; Chen R Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):924-6. PubMed ID: 22340884 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
18. Clinical application of serum CST4 combined with tumor markers in the diagnosis of digestive system malignant tumors. Zhou D; Fan X; Xie S; Lu M; Gao L; Zhang R; Zhu M Oncol Lett; 2024 Aug; 28(2):384. PubMed ID: 38966578 [TBL] [Abstract][Full Text] [Related]
19. Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study. Li X; Li S; Zhang Z; Huang D PeerJ; 2022; 10():e13488. PubMed ID: 35611170 [TBL] [Abstract][Full Text] [Related]
20. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients. Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]